These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 25503143

  • 41. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 42. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
    Zhang X, Huang H, Xu Z, Zhan R.
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
    [Abstract] [Full Text] [Related]

  • 43. Effects of daunorubicin on cell growth, cell cycle and induction of apoptosis in HL-60 cells.
    Chikayama S, Kimura S, Kobayashi Y, Abe T, Maekawa T, Kondo M.
    Haematologia (Budap); 1998 Sep; 29(2):115-21. PubMed ID: 9728803
    [Abstract] [Full Text] [Related]

  • 44. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A, Liu LF, Israel M, Seshadri R, Koseki Y, Giuliani FC, Kirschenbaum S, Silber R, Potmesil M.
    Cancer Res; 1989 Nov 01; 49(21):5969-78. PubMed ID: 2551497
    [Abstract] [Full Text] [Related]

  • 45. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K, Lahortiga I, Mentens N, Folens C, Van Neste L, Bekaert S, Vandenberghe P, Odero MD, Marynen P, Cools J.
    Haematologica; 2008 Apr 01; 93(4):533-42. PubMed ID: 18322257
    [Abstract] [Full Text] [Related]

  • 46. Drug sensitivity assay for leukaemic cells by flow cytometry.
    Gupta M, Naik S, Pandey CM, Dabadghao S.
    Indian J Med Res; 2002 Jun 01; 115():260-4. PubMed ID: 12440199
    [Abstract] [Full Text] [Related]

  • 47. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
    Taghdisi SM, Lavaee P, Ramezani M, Abnous K.
    Eur J Pharm Biopharm; 2011 Feb 01; 77(2):200-6. PubMed ID: 21168488
    [Abstract] [Full Text] [Related]

  • 48. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M, Oszczapowicz I, Wietrzyk J, Opolski A, Madej J, Dzimira S, Oszczapowicz J.
    Anticancer Res; 2005 Feb 01; 25(3B):2043-8. PubMed ID: 16158943
    [Abstract] [Full Text] [Related]

  • 49. Cytotoxicity, cellular uptake and DNA damage by daunorubicin and its new analogues with modified daunosamine moiety.
    Ciesielska E, Studzian K, Wasowska M, Oszczapowicz I, Szmigiero L.
    Cell Biol Toxicol; 2005 Feb 01; 21(3-4):139-47. PubMed ID: 16328893
    [Abstract] [Full Text] [Related]

  • 50. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G, Soranzo C, Zunino F.
    Cancer Res; 1986 Nov 01; 46(11):5499-503. PubMed ID: 3463414
    [Abstract] [Full Text] [Related]

  • 51. Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines.
    Szwed M, Laroche-Clary A, Robert J, Jozwiak Z.
    Chem Biol Interact; 2014 Sep 05; 220():140-8. PubMed ID: 24998637
    [Abstract] [Full Text] [Related]

  • 52. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
    Horton D, Khare A.
    Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6179-81. PubMed ID: 20850305
    [Abstract] [Full Text] [Related]

  • 53. Effect of doxorubicin and daunorubicin on the activity of acetylcholinesterase in acute lymphoblastic leukamia.
    Niazi IU, Tariq SA, Ali A.
    J Ayub Med Coll Abbottabad; 2011 Nov 01; 23(2):45-7. PubMed ID: 24800340
    [Abstract] [Full Text] [Related]

  • 54. [A study on apoptotic cell death during chemotherapy of patients with acute leukemia].
    Ren X, Gao H, Wang S.
    Zhonghua Zhong Liu Za Zhi; 1998 May 01; 20(3):191-2. PubMed ID: 10921004
    [Abstract] [Full Text] [Related]

  • 55. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C, Hassan HT.
    Leuk Res; 2006 Mar 01; 30(3):296-302. PubMed ID: 16112192
    [Abstract] [Full Text] [Related]

  • 56. Simple, semiautomatic assay of cytostatic and cytotoxic effects of antitumor drugs by laser scanning cytometry: effects of the bis-intercalator WP631 on growth and cell cycle of T-24 cells.
    Pozarowski P, Huang X, Gong RW, Priebe W, Darzynkiewicz Z.
    Cytometry A; 2004 Feb 01; 57(2):113-9. PubMed ID: 14750133
    [Abstract] [Full Text] [Related]

  • 57. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B, Dubrez L, Allouche M, Solary E.
    Cancer Res; 1997 Feb 15; 57(4):686-95. PubMed ID: 9044846
    [Abstract] [Full Text] [Related]

  • 58. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe.
    Cives M, Ciavarella S, Rizzo FM, De Matteo M, Dammacco F, Silvestris F.
    Cell Signal; 2013 May 15; 25(5):1108-17. PubMed ID: 23380051
    [Abstract] [Full Text] [Related]

  • 59. [Study on the sensitization of acute myeloid leukemia cell to daunorubicin by recombinant human interleukin-3].
    Wang J, Wang Q, Chen X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan 15; 20(1):30-2. PubMed ID: 11498841
    [Abstract] [Full Text] [Related]

  • 60. Induction of prophage lambda by daunorubicin and derivatives correlation with antineoplastic activity.
    Anderson WA, Moreau PL, Devoret R, Maral R.
    Mutat Res; 1980 Mar 15; 77(3):197-208. PubMed ID: 6446038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.